Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Daily News

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

Caitlin E. Cox

November 11, 2020

Presentation TCT 2016

Points to Consider in the Review of Endovascular Treatment Devices: US Regulatory View

Presenter: Schuyler Jones, Misti Malone, Eleni Whatley

October 30, 2016

Presentation TCT 2016

Points To Consider in the Review of Endovascular Treatment Devices: Japanese Regulatory View

Presenter: Schuyler Jones, Misti Malone, Shin Iwamoto

October 30, 2016

Presentation TCT 2016

Overview of the Clinical Trials for Atherectomy

Presenter: Schuyler Jones, Misti Malone, Brad Martinsen, PhD

October 30, 2016

Presentation TCT 2016

Overview of the Clinical Trials for Drug-Coated Balloons

Presenter: Schuyler Jones, Misti Malone, George Papandreou

October 30, 2016

Presentation TCT 2016

Japan Academia View

Presenter: Schuyler Jones, Misti Malone, Hiroyoshi Yokoi

October 30, 2016

Presentation TCT 2016

US Academia View

Presenter: Schuyler Jones, Misti Malone, Michael R. Jaff

October 30, 2016

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

Advertisement

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

PCI at Ambulatory Centers: More Bleeding but No Penalty in Overall Outcomes

Points to Consider in the Review of Endovascular Treatment Devices: US Regulatory View

Points To Consider in the Review of Endovascular Treatment Devices: Japanese Regulatory View

Overview of the Clinical Trials for Atherectomy

Overview of the Clinical Trials for Drug-Coated Balloons

Japan Academia View

US Academia View

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content